Published in PLoS One on October 06, 2014
Coxiella burnetii Infects Primary Bovine Macrophages and Limits Their Host Cell Response. Infect Immun (2016) 0.77
Salmonella Typhi Porins OmpC and OmpF Are Potent Adjuvants for T-Dependent and T-Independent Antigens. Front Immunol (2017) 0.75
Toll-like receptors. Annu Rev Immunol (2001) 26.06
Signaling to NF-kappaB. Genes Dev (2004) 19.78
Mammalian MAP kinase signalling cascades. Nature (2001) 18.89
Innate immunity: the virtues of a nonclonal system of recognition. Cell (1997) 9.42
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ (1999) 8.93
Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature (1994) 8.85
Control of B-cell responses by Toll-like receptors. Nature (2005) 6.44
Toll-like receptor signaling pathways. Science (2003) 5.86
Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol (2000) 4.73
The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med (1988) 4.31
Interleukin-10: new perspectives on an old cytokine. Immunol Rev (2008) 3.94
Pattern recognition receptors and control of adaptive immunity. Immunol Rev (2009) 3.91
Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol (2002) 3.27
Recognition of microbial infection by Toll-like receptors. Curr Opin Immunol (2003) 3.18
ERK implication in cell cycle regulation. Biochim Biophys Acta (2006) 2.96
Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin Microbiol Rev (2008) 2.86
Cytokine-producing B lymphocytes-key regulators of immunity. Curr Opin Immunol (2008) 2.84
Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. Proc Natl Acad Sci U S A (2007) 2.81
Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect Immun (1995) 2.80
Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation. Mol Cell Biol (1994) 2.75
Strategies for use of IL-10 or its antagonists in human disease. Immunol Rev (2008) 2.52
B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. J Immunol (1995) 2.29
Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo. J Exp Med (2003) 2.27
The complexity of signaling pathways activated by the BCR. Curr Opin Immunol (1997) 2.25
Cutting edge: Immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent. J Immunol (2002) 2.00
Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4. J Biol Chem (2003) 1.91
CD28/B7 costimulation: a review. Crit Rev Immunol (1998) 1.87
Immunoglobulin class-switch DNA recombination: induction, targeting and beyond. Nat Rev Immunol (2012) 1.80
Production of cytokines by human B cells in health and disease. Immunol Today (1997) 1.66
IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens. J Immunol (2008) 1.66
Roles of the NF-kappaB pathway in lymphocyte development and function. Cold Spring Harb Perspect Biol (2009) 1.63
Signaling in B cells via Toll-like receptors. Curr Opin Immunol (2005) 1.60
Crystal structure of Neisserial surface protein A (NspA), a conserved outer membrane protein with vaccine potential. J Biol Chem (2003) 1.54
Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J Immunol (1993) 1.50
Tyrosine kinases and their substrates in B lymphocytes. Immunol Rev (2009) 1.46
A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. Adv Immunol (2006) 1.42
Growing antimicrobial resistance of Shigella isolates. J Antimicrob Chemother (2003) 1.41
Toll-like receptors and innate immunity in B-cell activation and antibody responses. Curr Opin Immunol (2007) 1.37
Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond. Vaccine (2008) 1.35
Outer membrane protein A (OmpA): a new pathogen-associated molecular pattern that interacts with antigen presenting cells-impact on vaccine strategies. Vaccine (2002) 1.20
Regulating B-cell activation and survival in response to TLR signals. Immunol Cell Biol (2007) 1.17
B cell autonomous TLR signaling and autoimmunity. Autoimmun Rev (2008) 1.10
Outer membrane protein A of Escherichia coli O157:H7 stimulates dendritic cell activation. Infect Immun (2006) 1.01
ERKs induce expression of the transcriptional repressor Blimp-1 and subsequent plasma cell differentiation. Sci Signal (2011) 0.99
Antibodies for the treatment of bacterial infections: current experience and future prospects. Curr Opin Biotechnol (2008) 0.96
Activation of HIV-1 long terminal repeat transcription and virus replication via NF-kappaB-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds. J Biol Chem (1997) 0.96
Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model. PLoS One (2011) 0.94
Outer membrane protein A (OmpA) of Shigella flexneri 2a links innate and adaptive immunity in a TLR2-dependent manner and involvement of IL-12 and nitric oxide. J Biol Chem (2012) 0.90
Role of protein tyrosine kinase and Erk1/2 activities in the Toll-like receptor 2-induced cellular activation of murine B cells by neisserial porin. Clin Vaccine Immunol (2008) 0.87
Purification and characterization of an immunogenic outer membrane protein of Shigella flexneri 2a. Vaccine (2009) 0.86
Haemophilus influenzae vaccine candidate outer membrane protein P6 is not conserved in all strains. Hum Vaccin (2011) 0.85
A differential requirement for phosphoinositide 3-kinase reveals two pathways for inducible upregulation of major histocompatibility complex class II molecules and CD86 expression by murine B lymphocytes. Immunology (2003) 0.84
Positively selected codons in immune-exposed loops of the vaccine candidate OMP-P1 of Haemophilus influenzae. J Mol Evol (2007) 0.84
Outer membrane protein A (OmpA) from Shigella flexneri 2a: a promising subunit vaccine candidate. Vaccine (2013) 0.81
34 kDa MOMP of Shigella flexneri promotes TLR2 mediated macrophage activation with the engagement of NF-kappaB and p38 MAP kinase signaling. Mol Immunol (2010) 0.80